VLA.PA
Price:
$2.668
Market Cap:
$432.62M
Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera and/or heat-labile toxin producing Enterotoxigenic Escherichia coli bacterium; and VLA2001, a vaccine candidate against SARS-CoV-2. The company also develops VLA15, a vaccine candidate that has completed Phase II clinical trial against Borrelia; and VLA1553, a vaccine can...[Read more]
Industry
Biotechnology
IPO Date
2007-06-29
Stock Exchange
EURONEXT
Ticker
VLA.PA
According to Valneva SE’s latest financial reports and current stock price. The company's current Enterprise Value is 510.85M. This represents a change of -21.43% compared to the average of 650.21M of the last 4 quarters.
The mean historical Enterprise Value of Valneva SE over the last ten years is 573.21M. The current 510.85M Enterprise Value has changed 8.81% with respect to the historical average. Over the past ten years (40 quarters), VLA.PA's Enterprise Value was at its highest in in the December 2021 quarter at 2.24B. The Enterprise Value was at its lowest in in the September 2021 quarter at 0.
Average
573.21M
Median
311.08M
Minimum
235.79M
Maximum
2.16B
Discovering the peaks and valleys of Valneva SE Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 257.31%
Maximum Annual Enterprise Value = 2.16B
Minimum Annual Increase = -73.07%
Minimum Annual Enterprise Value = 235.79M
Year | Enterprise Value | Change |
---|---|---|
2023 | 737.04M | 26.71% |
2022 | 581.66M | -73.07% |
2021 | 2.16B | 257.31% |
2020 | 604.43M | 135.59% |
2019 | 256.56M | 8.81% |
2018 | 235.79M | -8.21% |
2017 | 256.87M | -7.58% |
2016 | 277.93M | -18.87% |
2015 | 342.58M | 22.53% |
2014 | 279.59M | 40.89% |
The current Enterprise Value of Valneva SE (VLA.PA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.16B
5-year avg
867.87M
10-year avg
573.21M
Valneva SE’s Enterprise Value is greater than Innate Pharma S.A. (135.23M), greater than DBV Technologies S.A. (20.54M), greater than Genfit S.A. (187.07M), less than Valneva SE (519.95M), greater than Nanobiotix S.A. (194.16M),
Company | Enterprise Value | Market cap |
---|---|---|
135.23M | $165.95M | |
20.54M | $70.99M | |
187.07M | $194.68M | |
519.95M | $492.54M | |
194.16M | $218.88M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Valneva SE using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Valneva SE or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Valneva SE's Enterprise Value?
What is the highest Enterprise Value for Valneva SE (VLA.PA)?
What is the 3-year average Enterprise Value for Valneva SE (VLA.PA)?
What is the 5-year average Enterprise Value for Valneva SE (VLA.PA)?
How does the current Enterprise Value for Valneva SE (VLA.PA) compare to its historical average?